Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Randomization modeling to ascertain clustering patterns of human papillomavirus types detected in cervicovaginal samples in the United States.

Querec TD, Gurbaxani BM, Unger ER.

PLoS One. 2013 Dec 18;8(12):e82761. doi: 10.1371/journal.pone.0082761. eCollection 2013.

2.

Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010.

Markowitz LE, Hariri S, Lin C, Dunne EF, Steinau M, McQuillan G, Unger ER.

J Infect Dis. 2013 Aug 1;208(3):385-93. doi: 10.1093/infdis/jit192. Epub 2013 Jun 19.

PMID:
23785124
3.

Detection of multiple human papillomavirus types in the lower genital tract correlates with cervical dysplasia.

Fife KH, Cramer HM, Schroeder JM, Brown DR.

J Med Virol. 2001 Aug;64(4):550-9.

PMID:
11468743
4.

Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the Linear array HPV genotyping test.

Coutlée F, Rouleau D, Petignat P, Ghattas G, Kornegay JR, Schlag P, Boyle S, Hankins C, Vézina S, Coté P, Macleod J, Voyer H, Forest P, Walmsley S; Canadian Women's HIV study Group, Franco E.

J Clin Microbiol. 2006 Jun;44(6):1998-2006.

5.

Prevalence and genotype distribution of human papillomavirus infection of the cervix in Spain: the CLEOPATRE study.

Castellsagué X, Iftner T, Roura E, Vidart JA, Kjaer SK, Bosch FX, Muñoz N, Palacios S, San Martin Rodriguez M, Serradell L, Torcel-Pagnon L, Cortes J; CLEOPATRE Spain Study Group.

J Med Virol. 2012 Jun;84(6):947-56. doi: 10.1002/jmv.23282.

PMID:
22499018
6.
7.

Human papillomavirus detection by hybrid capture in paired cervicovaginal lavage and cervical biopsy specimens.

Brown DR, Rawlings K, Handy V, Fife KH, Bryan JT, Cramer H, Graham M.

J Med Virol. 1996 Feb;48(2):210-4.

PMID:
8835357
8.

Prevalence of Human Papillomavirus in Self-Collected Cervicovaginal Swabs in Young Women in the United States Between 2003 and 2012.

Tarney CM, Klaric J, Beltran T, Pagan M, Han J.

Obstet Gynecol. 2016 Dec;128(6):1241-1247.

PMID:
27824760
9.

Prevalence of human papillomavirus among STD clinic attenders in Jamaica: association of younger age and increased sexual activity.

Figueroa JP, Ward E, Luthi TE, Vermund SH, Brathwaite AR, Burk RD.

Sex Transm Dis. 1995 Mar-Apr;22(2):114-8.

PMID:
7624812
10.

Human papillomavirus (HPV) genotyping using paired exfoliated cervicovaginal cells and paraffin-embedded tissues to highlight difficulties in attributing HPV types to specific lesions.

Gravitt PE, van Doorn LJ, Quint W, Schiffman M, Hildesheim A, Glass AG, Rush BB, Hellman J, Sherman ME, Burk RD, Wang SS.

J Clin Microbiol. 2007 Oct;45(10):3245-50. Epub 2007 Aug 15.

11.

Detection and genotyping of human papillomavirus in self-obtained cervicovaginal samples by using the FTA cartridge: new possibilities for cervical cancer screening.

Lenselink CH, de Bie RP, van Hamont D, Bakkers JM, Quint WG, Massuger LF, Bekkers RL, Melchers WJ.

J Clin Microbiol. 2009 Aug;47(8):2564-70. doi: 10.1128/JCM.00285-09. Epub 2009 Jun 24.

12.

Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples.

Coutlée F, Gravitt P, Kornegay J, Hankins C, Richardson H, Lapointe N, Voyer H, Franco E.

J Clin Microbiol. 2002 Mar;40(3):902-7.

13.

Prevalence and genotype distribution of cervical human papillomavirus (HPV) among women in urban Tianjin, China.

Chen X, Wallin KL, Duan M, Gharizadeh B, Zheng B, Qu P.

J Med Virol. 2015 Nov;87(11):1966-72. doi: 10.1002/jmv.24248. Epub 2015 Jun 12.

PMID:
26073652
14.

Assessing genital human papillomavirus genoprevalence in young Australian women following the introduction of a national vaccination program.

Osborne SL, Tabrizi SN, Brotherton JM, Cornall AM, Wark JD, Wrede CD, Jayasinghe Y, Gertig DM, Pitts MK, Garland SM; VACCINE Study group.

Vaccine. 2015 Jan 1;33(1):201-8. doi: 10.1016/j.vaccine.2014.10.045. Epub 2014 Nov 1.

PMID:
25444787
15.

Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening.

Učakar V, Poljak M, Oštrbenk A, Klavs I.

J Med Virol. 2014 Oct;86(10):1772-9. doi: 10.1002/jmv.23997. Epub 2014 Jun 30.

PMID:
24978445
16.

Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: a 7.5-year longitudinal study in a routine cytology-based screening population in West Germany.

Kovács K, Varnai AD, Bollmann M, Bankfalvi A, Szendy M, Speich N, Schmitt C, Pajor L, Bollmann R.

J Med Virol. 2008 Oct;80(10):1814-23. doi: 10.1002/jmv.21282.

PMID:
18712836
17.

Prevalence and risk profile of cervical Human papillomavirus infection in Zhejiang Province, southeast China: a population-based study.

Ye J, Cheng X, Chen X, Ye F, Lü W, Xie X.

Virol J. 2010 Mar 23;7:66. doi: 10.1186/1743-422X-7-66.

18.

High prevalence of high-risk oncogenic human papillomaviruses harboring atypical distribution in women of childbearing age living in Libreville, Gabon.

Si-Mohamed A, Ndjoyi-Mbiguino A, Cuschieri K, Onas IN, Colombet I, Ozouaki F, Goff JL, Cubie H, Bélec L.

J Med Virol. 2005 Nov;77(3):430-8.

PMID:
16173023
19.

Patterns of cervical coinfection with multiple human papilloma virus types in a screening population in Denmark.

Goldman B, Rebolj M, Rygaard C, Preisler S, Ejegod DM, Lynge E, Bonde J.

Vaccine. 2013 Mar 15;31(12):1604-9. doi: 10.1016/j.vaccine.2012.12.084. Epub 2013 Jan 10.

PMID:
23313651
20.

Carcinogenic HPV prevalence and age-specific type distribution in 40,382 women with normal cervical cytology, ASCUS/LSIL, HSIL, or cervical cancer: what is the potential for prevention?

Kjær SK, Munk C, Junge J, Iftner T.

Cancer Causes Control. 2014 Feb;25(2):179-89. doi: 10.1007/s10552-013-0320-z. Epub 2013 Nov 17.

PMID:
24242002

Supplemental Content

Support Center